Ligand Pharmaceuticals | LGND - Ebitda

Stock Price
198.53
Daily Change
-0.31 -0.16%
Monthly
3.38%
Yearly
69.24%
Q1 Forecast
186.18

Ligand Pharmaceuticals reported $20.9M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Amgen USD 5.91B 2.31B Sep/2025
Arrowhead Research USD 64.2M 223.53M Sep/2025
Baxter International USD 462M 137M Jun/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Glaxosmithkline GBP 4.75B 1.52B Sep/2025
Insmed USD -297.13M 71.11M Jun/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Ligand Pharmaceuticals USD 20.9M 61.44M Jun/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Pacira USD 49.36M 4.96M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Veracyte USD 39.73M 3.96M Sep/2025